氩氦冷冻消融在肺癌多学科综合治疗中的研究进展

肺癌是世界上发病率最高的恶性肿瘤之一,外科手术为首选治疗方式。近年来许多新兴微创技术治疗肺癌取得了良好效果。氩氦冷冻消融术因具有损伤小、恢复快、安全性高、并发症少等优点,已取得医患双方认可。冷冻消融适用于不能手术切除的早期肺癌及减少晚期肺癌负荷。肿瘤是一种全身性疾病,因此冷冻消融联合其他治疗方法将是未来肺癌治疗发展方向,从而改善患者临床症状,提高生活质量,延长生存时间,达到最佳治疗效果。该文就冷冻消融治疗及与其他方法综合治疗肺癌研究现状和进展作一综述。

Research progress of argon-helium cryoablation in multi-disciplinary comprehensive treatment of lung cancer

Lung cancer is one of the most common malignant tumors in the world, for which surgery has been the first choice of treatment. In recent years, many newly-developed minimally-invasive techniques have achieved satisfactory therapeutic effects in treating lung cancer. Because of its adavantages of small injury, fast recovery, high safety and less complications, argon-helium cryoablation for the treatment of lung cancer has been recognized by both doctors and patients. Cryoablation therapy is suitable for the patients with inoperable early lung cancer and for the patients who need to reduce the tumor load of advanced lung cancer. As tumor is a systemic disease, combination use of cryoablation and other treatments will be the development direction of lung cancer treatment in the future so as to improve the clinical symptoms and the quality of life, prolong the survival time, and achieve the best therapeutic effect. This article aims to make a comprehensive review about the current research status and the progress of cryoablation therapy and its combination with other therapeutic methods in the treatment of lung cancer.